Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 8.755\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a: CCn1nnc(-c2ccccc2NC(=O)c2cc(OC)cc(OC)c2)n1
b: Cc1nc(N2CCN(S(=O)(=O)c3ccc(F)cc3)CC2)c2c(-c3cccs3)csc2n1
Answer: b. Cc1nc(N2CCN(S(=O)(=O)c3ccc(F)cc3)CC2)c2c(-c3cccs3)csc2n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1nc(N2CCN(S(=O)(=O)c3ccc(F)cc3)CC2)c2c(-c3cccs3)csc2n1
Cc1nc(N2CCN(S(=O)(=O)c3ccc(F)cc3)CC2)c2c(-c3cccs3)csc2n1
4-[4-(4-fluorophenyl)sulfonylpiperazin-1-yl]-2-methyl-5-thiophen-2-ylthieno[2,3-d]pyrimidine